Related Experiment Video
Updated: Mar 9, 2026
03:47
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
723
Thoracic surgical interventions for DR-TB and their results
1Department of Thoracic Surgery, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.
International Journal of Mycobacteriology
|January 4, 2017
Summary
Surgery for drug-resistant tuberculosis (DR-TB) can significantly improve patient outcomes and quality of life. Surgical intervention is recommended for selected DR-TB patients, especially those with localized disease or persistent symptoms despite treatment.
Area of Science:
- Pulmonary Medicine
- Thoracic Surgery
- Infectious Diseases
Background:
- Surgery for drug-resistant tuberculosis (DR-TB) is often debated but offers significant benefits in select cases.
- Indications include localized disease, persistent symptoms, or lack of improvement with standard therapy.
- Surgical intervention can improve treatment outcomes and patient quality of life.
Purpose of the Study:
- To evaluate the role and outcomes of surgical intervention in patients with drug-resistant tuberculosis.
- To assess the efficacy of various surgical procedures in achieving sputum negativity and cure.
Main Methods:
- A retrospective analysis of 107 patients undergoing surgery for DR-TB at NITRD over 20 years.
- Surgical procedures included pneumonectomies, lobectomies, bilobectomies, nonanatomical resections, and thoracoplasties.
Main Results:
- 93 out of 107 patients achieved sputum negativity post-surgery.
- 62 patients were declared cured after a 4-year follow-up period.
- A separate cohort of 6 DR-TB patients operated on in 2013 remained sputum-negative by March 2015.
Conclusions:
- Surgical intervention is a valuable and effective treatment option for carefully selected DR-TB patients.
- Increased availability and accessibility of surgical services for DR-TB are recommended.
Related Concept Videos
01:28Pulmonary Tuberculosis V
719
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
719
01:27Pneumothorax-II
1.3K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
1.3K
01:26Pulmonary Tuberculosis IV
592
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
592
01:29Pulmonary Tuberculosis I
1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
01:28Pulmonary Tuberculosis II
1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
01:31Pulmonary Tuberculosis III
1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.3K